Company / Profit Margin
Day One Biopharmaceuticals, Inc. Profit Margin History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-67.8%
FY2025
5-year range
-72.8% / -67.8%
FY2024-FY2025
Trend
+6.8%
vs FY2024
Sector context
#90 of 143
Health Care
What the data says
At -67.8%, Day One Biopharmaceuticals, Inc.'s profit margin ranks #90 of 143 in the Health Care sector.
Based on SEC 10-K filings.
-67.8% in FY2025.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#90 of 143 in Health CareTop 63% of 143This company -67.8% Sector average -899.4%
▼
+92.5% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 6.8% year-over-year.
- Currently 831.5pp above the Health Care sector average.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -67.8% | +6.8% |
| FY2024 | -72.8% | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026